开放主动脉修复后复发病变及围手术期并发症的二次血管内修复:不同技术方案的互补作用
本文描述开放主动脉修复(OAR)后复发病变及围手术期并发症的二次血管内修复中不同技术方案的互补作用。结论认为二次血管内修复安全可行,不同技术方案互补而非竞争。
要点
- OAR后复发病变或并发症的二次血管内修复技术成功率100%。
- 6例中1例30天内死于急性肺栓塞,1例发生急性肾损伤。
- F-BEVAR、pg-EVAR和超适应症使用标准器械互为补充。
核心结论
- OAR后复发病变及围手术期并发症的二次血管内修复安全可行,为再次外科手术高风险患者提供微创有效治疗选择。
- 不同技术方案(F-BEVAR、pg-EVAR、超适应症使用标准器械)互补而非竞争。
- 充分的术前评估和熟练掌握高级技术对获得满意结果至关重要。
研究设计与样本
- 单中心临床经验描述性研究,纳入2015年1月1日至2018年6月31日连续6例OAR后出现复发病变或围手术期并发症并接受二次血管内修复的患者,包括择期和非择期病例。
主要发现
- 6例患者中2例采用F-BEVAR,2例采用pg-EVAR,2例采用标准器械超适应症使用。
- 技术成功率100%;1例30天内死于急性肺栓塞。
- 1例发生急性肾损伤但无需肾脏替代治疗,其余4例30天内无主要不良事件。
- 30天血管入路并发症累积率0%。
- 5例存活出院患者均有≥12个月临床和影像随访,最长个体随访时全部存活且免于二次干预,CT血管造影显示持续临床成功。
关键数值与推荐
- 早期终点包括技术成功、30天死亡率、30天主要不良事件和30天血管入路并发症。
- 晚期终点包括生存率和免于二次干预率。
临床怎么用
- 对于OAR后复发病变或围手术期并发症且再次外科手术风险高的患者,可考虑二次血管内修复。
- 根据病变特点选择F-BEVAR、pg-EVAR或超适应症使用标准器械,这些技术互为补充。
- 术前需仔细评估并熟悉高级血管内技术以取得满意结果。
局限性
- 样本量小(仅6例),为单中心经验描述。
- 随访时间有限,最长个体随访≥12个月。
- 未设对照组,无法比较不同技术或与再次开放手术的优劣。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aim of our article was to describe the complementary role of different technical solutions for secondary endovascular repair of recurring lesions and perioperative complications after open aortic repair (OAR). METHODS: We describe our clinical experience of secondary endovascular repair after OAR. We included in the analysis all consecutive patients who presented recurring lesions and perioperative complications after OAR and underwent secondary endovascular repair between January 1, 2015 and June 31, 2018. Both elective and nonelective cases were captured. Early end points were technical success, 30-day mortality, 30-day major adverse events, and 30-day vascular access complications. Late end points were survival and freedom from secondary interventions. RESULTS: Three different techniques were used in 6 patients: 2 cases of fenestrated-branched endovascular aortic repair (F-BEVAR), 2 cases of parallel-graft EVAR (pg-EVAR), and 2 cases of off-label use of standard devices. Technical success was 100%. One patient died within 30 days from acute pulmonary embolism. One patient developed acute kidney injury not requiring renal replacement therapy, whereas the remaining 4 patients were free from 30-day major adverse events. The cumulative rate of 30-day vascular access complications was 0%. All the 5 patients who survived the index hospitalization had ≥12 months of clinical and imaging follow-up. At the longest individual follow-up, they all were alive and free from secondary interventions. Computed tomography angiography showed in all cases sustained clinical success. CONCLUSIONS: Secondary endovascular repair of recurring lesions and perioperative complications after OAR is safe and feasible and offers a minimally invasive effective treatment option when a redo surgical operation would be associated with a considerable risk to the patient. Different solutions are available (including F-BEVAR, pg-EVAR, and off-label use of standard devices) and are complementary rather than competitive. Careful preoperative assessment and familiarity with advanced techniques are essential to achieve satisfactory outcomes.
引用
- D'Oria M, Mastrorilli D, Calvagna C, et al. Secondary Endovascular Repair of Recurring Lesions and Perioperative Complications after Open Aortic Repair: The Complementary Role of Different Technical Solutions. Ann Vasc Surg. 2019. PMID: 31449951. doi:10.1016/j.avsg.2019.06.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。